NewsSeptember 18, 2008
RFL Chair Ron Weiss Makes “The Case for Personalized Medicine” in Health Affairs BlogPersonalized medicine and genetic testing offer cost-savings and improved health care for Americans and have the potential to impact the quality and cost of health care as much as any other issue currently on the US health care reform radar. That was the view expressed by Dr. Ronald Weiss, President and Chief Operating Officer, of ARUP Labs and Chairman of the Results for Life campaign, in a posting on the prestigious blog of Health Affairs, a health policy journal read widely by policymakers, legislators, and the news media. Dr. Weiss emphasized that genetic testing enables significant improvements in a range of medical conditions—from breast cancer to cardiovascular conditions—and that tailored therapy brought about by genetic testing promises fewer side-effects, cost savings, and more effective treatment.Click to read the piece at Health Affairs
|
|
2010 Copyright American Clinical Laboratory Association 1100 New York Avenue, NW, Suite 725 West, Washington, DC 20005 - (P): 202-637-9466 Email: info@labresultsforlife.org - Terms and Conditions |